The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

E. H. Ibrahim, G. Sherman, S. Ward, V. J. Fraser, M. H. Kollef (Alexandria, Egypt; Saint Louis, United States Of America)

Source: Annual Congress 2003 - Epidemiology, therapy and outcome of infections in the ICU
Session: Epidemiology, therapy and outcome of infections in the ICU
Session type: Oral Presentation
Number: 231
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. H. Ibrahim, G. Sherman, S. Ward, V. J. Fraser, M. H. Kollef (Alexandria, Egypt; Saint Louis, United States Of America). The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Eur Respir J 2003; 22: Suppl. 45, 231

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Does the management and outcome of community-acquired pneumonia differ depending on the route of admission to hospital?
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009


The influence of inadequate starting empirical antimicrobial therapy of septic pneumonia on outcomes at patients with angiogenic sepsis
Source: Eur Respir J 2004; 24: Suppl. 48, 549s
Year: 2004

Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens
Source: Eur Respir J 2002; 20: 432-439
Year: 2002



Are severity scores for community acquired pneumonia being used in secondary care and its impact on appropriateness of antibiotic therapy - a retrospective study
Source: Eur Respir J 2004; 24: Suppl. 48, 187s
Year: 2004

Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care
Source: Eur Respir J 2006; 27: 1223-1228
Year: 2006



Effect on outcome of antibiotic treatment during the 2 weeks before hospital admission for community acquired pneumonia
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010


Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005

Influence on the prognosis of misuse of antibiotics prior to admission in patients with community acquired pneumonia
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010


Comparison of invitro antimicrobial susceptibility tests of patients admitted in a tertiary respiratory center intensive care unit with their clinical symptoms related to ventilator associated pneumonia (in vivo results)
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012

The impact of a delay in intensive care unit admission for community-acquired pneumonia
Source: Eur Respir J 2010; 36: 826-833
Year: 2010



Previous antibacterial therapy and drug-resistance among pathogens in ICU patients with nosocomial pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 405s
Year: 2001

The APO-audit in the primary health care of archangelsk region: the way to the effective therapy of community-acquired respiratory infections
Source: Annual Congress 2009 - Diagnostic strategies in primary respiratory care
Year: 2009


The impact of a stewardship programme on outcomes in patients admitted with community-acquired pneumonia
Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections
Year: 2020




Antibiotic use
Source: Annual Congress 2005 - Protocols in the critically ill patient
Year: 2005

Appropriateness and delay to initiate therapy in ventilator-associated pneumonia
Source: Eur Respir J 2006; 27: 158-164
Year: 2006



Epidemiology, clinical features and risk factors for adverse outcome of patients with pulmonary tuberculosis (TB) in an intensive care unit (ICU)
Source: Annual Congress 2003 - Epidemiology, therapy and outcome of infections in the ICU
Year: 2003


Prognosis factors influencing three-month respiratory outcomes in intensive care unit survivors after COVID-19 pneumonia
Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure
Year: 2021


Differences in clinical courses of nosocomial pneumonia between patients of surgical and therapeutic departments
Source: Eur Respir J 2006; 28: Suppl. 50, 787s
Year: 2006

Optimising the duration of antibiotic therapy for ventilator-associated pneumonia
Source: Eur Respir Rev 2007; 16: 40-44
Year: 2007



Etiological organisms from patients with hospital acquired pneumonia and its mortality in the respiratory intensive care unit
Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia
Year: 2007